Sabra Health Care REIT, Inc. (SBRA)
- Previous Close
17.50 - Open
17.61 - Bid 17.72 x 200
- Ask 17.80 x 200
- Day's Range
17.51 - 17.78 - 52 Week Range
13.87 - 20.03 - Volume
3,113,635 - Avg. Volume
2,558,350 - Market Cap (intraday)
4.226B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
29.60 - EPS (TTM)
0.60 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield 1.20 (6.76%)
- Ex-Dividend Date May 16, 2025
- 1y Target Est
19.58
As of September 30, 2024, Sabra's investment portfolio included 373 real estate properties held for investment (consisting of (i) 233 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (senior housing - leased), (iii) 68 senior housing communities operated by third-party property managers pursuant to property management agreements (senior housing - managed), (iv) 18 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2024, Sabra's real estate properties held for investment included 37,793 beds/units, spread across the United States and Canada.
www.sabrahealth.com50
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA
View More
Performance Overview: SBRA
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA
View MoreValuation Measures
Market Cap
4.23B
Enterprise Value
6.62B
Trailing P/E
29.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.86
Price/Book (mrq)
1.56
Enterprise Value/Revenue
9.20
Enterprise Value/EBITDA
15.55
Financial Highlights
Profitability and Income Statement
Profit Margin
19.54%
Return on Assets (ttm)
3.14%
Return on Equity (ttm)
5.15%
Revenue (ttm)
720.25M
Net Income Avi to Common (ttm)
140.76M
Diluted EPS (ttm)
0.60
Balance Sheet and Cash Flow
Total Cash (mrq)
37.89M
Total Debt/Equity (mrq)
88.89%
Levered Free Cash Flow (ttm)
271.17M
Research Analysis: SBRA
View MoreResearch Reports: SBRA
View MoreWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target